Fig. 1From: Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edemaMean CMT, BCVA, and IOP with intravitreal and sub-Tenon’s capsule triamcinolone acetonide injection. Values were measured at baseline and at 1, 2 and 3 months after treatment. BCVA, best-corrected visual acuity; CMT, central macular thickness; IOP, intraocular pressureBack to article page